Efavirenz

Efavirenz is an antiviral medication used to treat HIV/AIDS. It belongs to a class of medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It works by blocking an enzyme that is required for HIV to replicate, thereby reducing the amount of virus in the body. Efavirenz is usually taken with other medications as part of a combination HIV treatment regimen. It is not a cure for HIV, but it can help to control the virus and reduce the risk of developing AIDS. Common side effects include headache, dizziness, and insomnia.

Efavirenz is a medication used along with other medications to treat HIV infection. Here's a breakdown of its key aspects:

Function:

  • Efavirenz belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs).
  • It works by interfering with an enzyme called reverse transcriptase, which is crucial for HIV to multiply in the body. By blocking this enzyme, Efavirenz helps reduce the amount of HIV virus in the blood.

Benefits:

  • Efavirenz does not cure HIV, but it can significantly suppress the virus. This can:
    • Improve a person's immune system function
    • Reduce the risk of developing complications from HIV infection, such as opportunistic infections (infections caused by organisms that wouldn't normally cause illness in a healthy person) and some cancers.
    • Increase life expectancy for people with HIV.

Dosage and Administration:

  • Efavirenz is typically taken as a capsule or tablet once daily, usually at bedtime because it can cause dizziness.
  • It is always used in combination with other HIV medications to prevent the virus from developing resistance to any single drug.

Side Effects:

  • Common side effects of Efavirenz can include:
    • Dizziness
    • Headache
    • Fatigue
    • Nausea
    • Vivid dreams or nightmares
    • Skin rash
  • Efavirenz can also interact with other medications, so it's important to tell your doctor about all the medications you are taking before starting Efavirenz.

Important Considerations:

  • Efavirenz is not recommended for pregnant women as it can cause birth defects. Women taking Efavirenz should use effective contraception to prevent pregnancy.
  • Efavirenz can also affect liver function, so regular monitoring may be needed.

It is important to note that this is just a general overview, and you should always consult with a doctor for specific information and guidance regarding Efavirenz or any other medication.

Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AG Non-nucleoside reverse-transcriptase inhibitors
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
External Links